CAPS   $7.5  -6.25% Market Open

CAPSTONE THERAPEUTICS
Total Cash 17.00K
totalCashPerShare 0.108
EBITDA -950.00K
Total Debt 3.07M
quickRatio 0.176
currentRatio 1.142
Total Revenue 48.35M
debtToEquity
Revenue/Share 306.795
ROA -0.013309999
ROE -0.1223
grossProfits
freeCashflow 2.45M
operatingCashflow 1.45M
earningsGrowth
revenueGrowth
grossMargins 0.19875999
ebitdaMargins -0.019650001
operatingMargins -0.025980001
profitMargins -0.07898
enterpriseValue 2.92M
forwardPE
floatShares
sharesOutstanding 157.61K
sharesShort 27.00
sharesShortPriorMonth 33.00
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline 0.35%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 15.462
Price To Book help_outline 0.21
earningsQuarterlyGrowth
netIncomeToCommon -5.74M
trailingEps -39.33%
forwardEps
enterpriseToEbitda -3.07
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 7, 2024, 9:22 a.m.